Chong Qiu | Nanomedicine | Young Scientist Award

Posted on by ScienceFather

Assoc Prof Dr. Chong Qiu | Artificial Intelligence | Young Scientist Award

Associate Professor at China Academy of Chinese Medical Sciences, China

Dr. Chong Qiu is an Associate Professor at the Artemisinin Research Center and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences. He earned his PhD from Peking University, specializing in nanocarriers for drug delivery, siRNA, and peptide therapeutics. Dr. Qiuā€™s research focuses on innovative nanoparticle-based drug delivery systems, with applications in cancer treatment, pulmonary fibrosis, and targeted gene therapies. His work is widely recognized, with numerous high-impact publications in prestigious journals like Nature Communications and Journal of Nanobiotechnology. He is also a board member of several scientific journals and a leading expert in his field.

Publication profile

Education:

  • PhD in Pharmaceutical Science, Peking University, 2019
  • Bachelorā€™s degree, Peking University, 2014

Research Interests:

  • Nanocarriers for siRNA delivery
  • Nano-carriers for oral protein and peptide
  • Targeted nanoparticulate drug delivery

Professional Roles:

  • Young Scientist Board Member for Asian Journal of Pharmaceutical Sciences, iMeta, and Traditional Medicine Research and Exploration

Publication

  1. Photoaffinity probe-based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of Plasmodium falciparum
    Journal: iMeta
    Year: 2024
    DOI: 10.1002/IMT2.176
    Contributors: Gao, Peng; Wang, Jianyou; Qiu, Chong; Zhang, Huimin; Wang, Chen; Zhang, Ying; Sun, Peng; Chen, Honglin; Wong, Yin Kwan; Chen, Jiayun et al.

 

  1. Enhanced tumor penetration across the blood-brain barrier: endoplasmic reticulum membrane hybrid siRNA nanoplexes
    Journal: Materials Today Nano
    Year: 2024
    DOI: 10.1016/j.mtnano.2023.100442
    Contributors: Chong Qiu; Shun Tao Liang; Qing Chao Tu; Chen Pan; Jia Yin Han; Bo Wu; Qiu Yan Guo; Yu Qian Lu; Jun Zhe Zhang; Yu Qing Meng et al.

 

  1. Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery
    Journal: Research
    Year: 2023
    DOI: 10.34133/RESEARCH.0148
    Contributors: Qiu, Chong; Xia, Fei; Zhang, Junzhe; Shi, Qiaoli; Meng, Yuqing; Wang, Chen; Pang, Huanhuan; Gu, Liwei; Xu, Chengchao; Guo, Qiuyan et al.

 

  1. Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy
    Journal: International Journal of Biological Sciences
    Year: 2023
    DOI: 10.7150/ijbs.79328
    Contributors: Chong Qiu; Yanyan Wu; Qiaoli Shi; Qiuyan Guo; Junzhe Zhang; Yuqing Meng; Chen Wang; Fei Xia; Jigang Wang; Chengchao Xu

 

  1. Anemoside B4 alleviates neuropathic pain through inhibiting inflammation
    Source: ResearchSquare
    Year: 2022
    DOI: 10.21203/rs.3.rs-1821028
    Contributors: Zhao, M.; Li, H.; Yang, T.; Qiu, C.; Lu, T.; Wang, Q.; Guo, Q.; Wang, J.

 

  1. Preparation and application of calcium phosphate nanocarriers in drug delivery
    Journal: Materials Today Bio
    Year: 2022
    DOI: 10.1016/j.mtbio.2022.100501
    Contributors: Chong Qiu; Yanyan Wu; Qiuyan Guo; Qiaoli Shi; Junzhe Zhang; Yuqing Meng; Fei Xia; Jigang Wang

 

šŸ† Conclusion

Dr. Chong Qiu is highly suitable for a Young Scientist Award. His innovative research, strong publication record, and leadership roles in the field of nanotechnology-based drug delivery make him a compelling candidate. With some strategic improvements in expanding research impact and fostering international collaborations, he has the potential to significantly advance the scientific community’s understanding of targeted therapeutics.

 

Hariharan Thirumalai Vengateswaran | Nanotechnology | Young Scientist Award

Posted on by ScienceFather

Mr. Hariharan Thirumalai Vengateswaran | Nanotechnology | Young Scientist Award

Dr at B. S. Abdur Rahman Crescent Institute of Science and Technology, India

Hariharan Thirumalaivengateswaran is an aspiring pharmacist with a strong academic record at B. S. Abdur Rahman Crescent Institute of Science and Technology, expected to graduate in March 2025 with a remarkable CGPA of 9.71. Specializing in nanoparticle synthesis and pharmaceutical R&D, Hariharan has excelled in scientific writing and communication, presenting research at international conferences and publishing in prestigious journals. With hands-on experience in nanocomposite development and computational techniques, he aims to advance biomedical sciences through innovative research. Hariharan also actively participates in workshops and webinars, demonstrating a commitment to continuous learning and professional development in pharmacy.

profile:

Scholar

šŸ§Ŗ Expertise

Nanoparticle synthesis, Scientific writing and publication, Pharmaceutical research and development, Strong written and oral communication skills

šŸŽ“ Education

Bachelor of Pharmacy B. S. Abdur Rahman Crescent Institute of Science and Technology, Vandalur, Tamil Nadu 2021 – 2025 (Expected Graduation: March 2025) CGPA: 9.71/10 (till 5th semester). Higher Secondary Education Kendriya Vidyalaya Sangathan no.2, Mangaluru, Karnataka 2020 – 2021 Graduated: April 2021 CGPA: 80%

šŸ”¬ Research

Development and characterization of carboxylated copper oxide conjugated polymeric nanocomposites and correlating with computational techniques Mentor: Dr. Mohammad Habeeb Institution: SRM Institute of Science and Technology, B. S. Abdur Rahman Crescent Institute of Science and Technology, Department of Pharmaceutics Presented findings at the 2024 International Conference on Advanced Functional Materials and Devices. Artificial Intelligence-based Network Biology on Pancreatic Cancer KRAS Onco Gene Associate RALGDS Targeted Inhibitors Mentor: Dr. Irfan Navabshan. Institution: B. S. Abdur Rahman Crescent Institute of Science and Technology, Department of Pharmaceutical Chemistry Evaluated the efficacy of RALGDS inhibitors integrating AI in pancreatic cancer treatment

šŸ“š Publications

  • Several articles in peer-reviewed journals and book chapters, including “Nanomedicine facilitated cell signaling blockade” in Journal of Materials Chemistry B (IF: 7.5)

šŸŽ“ Conferences & Webinars

  • Participated in international conferences and webinars on translational research, scientific writing, pharmacovigilance, and more

šŸ† Honors & Awards

  • Recognized at various academic and professional events, including World Pharmacist Day by Pfizer R&D and National Youth Parliament

šŸ”§ Workshop & Courses

Attended workshops on pharmacovigilance, in-silico modeling in drug development, AI for journal abstract matching, and more

šŸ‘©ā€šŸ« Experience

  • Project assistant (Part-time) at D3 Drug Tech Limited, experienced in insilico work This summary highlights your academic achievements, research projects, skills, and professional engagements effectively.

Publication:šŸ“

Title: Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma
Authors: M Habeeb, HT Vengateswaran, HW You, K Saddhono, KB Aher, …
Journal: Journal of Materials Chemistry B
Year: 2024
Citations: 1

 

Katherine SimbaƱa Rivera | Biomedicina | Young Scientist Award

Posted on by ScienceFather

Dr. Katherine SimbaƱa Rivera | Biomedicina | Young Scientist Award

Assistant Professor at Pontificia Universidad CatĆ³lica del Ecuador, Ecuador

Summary:

Katherine SimbaƱa Rivera is a medical doctor and researcher dedicated to advancing medical knowledge and public health initiatives through extensive research and collaborative networks. With a background in molecular biomedicine and significant experience in health research management, she has authored numerous articles and co-authored books on critical health topics. Her leadership in national health research and active involvement in student scientific societies underline her commitment to fostering research capabilities and promoting healthcare access in underserved communities across Latin America.

Profile:

Scopus

Orcid

Google Scholar

šŸŽ“Education:

Katherine SimbaƱa Rivera earned her medical degree from Universidad Central del Ecuador. She further pursued a Master’s degree in Molecular Biomedicine, specializing in Basic and Translational Cancer Research, from the Universitat de Barcelona, Spain. Currently, she is enrolled in doctoral studies in Applied Health Sciences Research at the University Institute of Biomedical and Health Research (IUIBS) at Universidad de Las Palmas de Gran Canaria, Spain.

šŸ„šŸ‘Øā€šŸ«Professional Experience:

From 2021 to 2022, Katherine served as the National Director of Health Research at the Ecuadorian Ministry of Public Health, where she played a key role in drafting nine research and bioethics regulations and developing strategic guidelines for national health management. She is currently an associate researcher at the Center for Research on Health in Latin America (CISeAL) at Pontificia Universidad CatĆ³lica del Ecuador (PUCE).

Research Interests:

Katherine SimbaƱa Rivera’s research interests encompass a broad spectrum, including the Ecuadorian pharmaceutical market, COVID-19, translational cancer research, and applied health sciences. Her work focuses on advancing public health through innovative research methodologies and strategic health interventions.

Publications Top Notes šŸ“:

1. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

  • Authors: Ortiz-Prado, E., SimbaƱa-Rivera, K., GĆ³mez-Barreno, L., Rubio-Neira, M., …
  • Journal: Diagnostic Microbiology and Infectious Disease
  • Volume: 98
  • Issue: 1
  • Year: 2020
  • Article Number: 115094
  • Citations: 543

2. Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador

  • Authors: Ortiz-Prado, E., SimbaƱa-Rivera, K., Barreno, L.G., Diaz, A.M., Barreto, A., …
  • Journal: PLoS Neglected Tropical Diseases
  • Volume: 15
  • Issue: 1
  • Year: 2021
  • Article Number: e0008958
  • Citations: 171

3. Anxiety and depression in patients with confirmed and suspected COVID-19 in Ecuador

  • Authors: Paz, C., Mascialino, G., Adana DĆ­az, L., RodrĆ­guez Lorenzana, A., …
  • Journal: Psychiatry and Clinical Neurosciences
  • Volume: 74
  • Issue: 10
  • Year: 2020
  • Pages: 554-555
  • Citations: 109

4. Behavioral and sociodemographic predictors of anxiety and depression in patients under epidemiological surveillance for COVID-19 in Ecuador

  • Authors: Paz, C., Mascialino, G., Adana-DĆ­az, L., RodrĆ­guez-Lorenzana, A., …
  • Journal: PLoS One
  • Volume: 15
  • Issue: 9
  • Year: 2020
  • Article Number: e0240008
  • Citations: 80

5. The disease burden of suicide in Ecuador, a 15 yearsā€™ geodemographic cross-sectional study (2001ā€“2015)

  • Authors: Ortiz-Prado, E., SimbaƱa, K., GĆ³mez, L., Henriquez-Trujillo, A.R., …
  • Journal: BMC Psychiatry
  • Volume: 17
  • Issue: 1
  • Year: 2017
  • Pages: 1-11
  • Citations: 56